Systematic review / meta-analysis / 2021
Coffee consumption was linked to a lower risk of incident chronic kidney disease, ESKD, albuminuria, and CKD-related mortality.
A systematic review and meta-analysis of 12 clinical studies (7 prospective, 5 cross-sectional) involving 505,841 subjects investigated the relationship between coffee intake and renal outcomes. Coffee consumption was associated with a significantly decreased risk of incident CKD (RR 0.86, 95% CI 0.76 to 0.97, P = .01), with a greater decrease seen with ≥2 cups/day versus ≤1 cup/day. Significant risk reductions were also found for incident ESKD (HR 0.82, 95% CI 0.72 to 0.94, P = .005), albuminuria (OR 0.81, 95% CI 0.68 to 0.97, P = .02), and CKD-related death (HR 0.72, 95% CI 0.54 to 0.96, P = .02).
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of observational studies
- Who was studied
- 505,841 subjects across 12 studies (7 prospective, 5 cross-sectional)
- What was measured
- Incidence of CKD, end-stage kidney disease (ESKD), albuminuria, and CKD-related mortality
THE PAPER
Effect of Coffee Consumption on Renal Outcome: A Systematic Review and Meta-Analysis of Clinical Studies.
Kanbay M, Siriopol D, Copur S, Tapoi L, Benchea L, Kuwabara M, Rossignol P, Ortiz A, Covic A, Afsar B. J Ren Nutr, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.